Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filemon K Tan

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 26, 2010
HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cellsStefania Lenna, Danyelle M Townsend, Filemon K Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype"Xiaodong Zhou, Filemon K Tan, Dianna M Milewicz, et al.
Arthritis and Rheumatism|January 11, 2005
Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblastsXiaodong Zhou, Filemon K Tan, Xinjian Guo, et al.
The American Journal of Medicine|August 9, 2005
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosisShervin Assassi, Maureen D Mayes, Terry McNearney, et al.
Arthritis and Rheumatism|April 29, 2006
Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcomeAna M Bertoli, Mónica Fernández, Gerald McGwin, et al.
Arthritis Research & Therapy|January 13, 2011
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblastsSandeep K Agarwal, Minghua Wu, Christopher K Livingston, et al.
Arthritis and Rheumatism|January 20, 2004
Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma)Debra D Wallis, Filemon K Tan, Rebecca Kessler, et al.
Arthritis and Rheumatism|November 13, 2002
Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to sclerodermaXiaodong Zhou, Filemon K Tan, John D Reveille, et al.
Arthritis and Rheumatism|November 30, 2006
Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosisPravitt Gourh, Filemon K Tan, Shervin Assassi, et al.
Arthritis and Rheumatism|September 18, 2003
Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalenceXiaodong Zhou, Filemon K Tan, Ning Wang, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|March 26, 2010
HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cellsStefania Lenna, Danyelle M Townsend, Filemon K Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype"Xiaodong Zhou, Filemon K Tan, Dianna M Milewicz, et al.
Arthritis and Rheumatism|January 11, 2005
Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblastsXiaodong Zhou, Filemon K Tan, Xinjian Guo, et al.
The American Journal of Medicine|August 9, 2005
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosisShervin Assassi, Maureen D Mayes, Terry McNearney, et al.
Arthritis and Rheumatism|April 29, 2006
Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcomeAna M Bertoli, Mónica Fernández, Gerald McGwin, et al.
Arthritis Research & Therapy|January 13, 2011
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblastsSandeep K Agarwal, Minghua Wu, Christopher K Livingston, et al.
Arthritis and Rheumatism|January 20, 2004
Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma)Debra D Wallis, Filemon K Tan, Rebecca Kessler, et al.
Arthritis and Rheumatism|November 13, 2002
Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to sclerodermaXiaodong Zhou, Filemon K Tan, John D Reveille, et al.
Arthritis and Rheumatism|November 30, 2006
Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosisPravitt Gourh, Filemon K Tan, Shervin Assassi, et al.
Arthritis and Rheumatism|September 18, 2003
Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalenceXiaodong Zhou, Filemon K Tan, Ning Wang, et al.
Pageof 7